CCL11 and neurodegenerative disease: Recent studies focusing on specific neurodegenerative diseases, such asAlzheimer’s disease, HD, ALS, SPMS, and CTE, also presented similar tendencies,implying an essential role of CCL11 as a potential neuroinflammation biomarkerfor distinguishing between different neuroinflammation conditions and therapeutictargets in these disorders [44, 45, 46, 47, 48, 49, 50, 51, 52, 53].